Iain Keith Moppett

Iain Keith Moppett

Auto-generated profile, based on publicly available information

Iain Keith Moppett

University of Nottingham Nottingham UK

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2008 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
MMM. J. Maxwell
M. J. Maxwell
CMC. G. Moran
C. G. Moran
IMI. K. Moppett
I. K. Moppett
Hip fractures are common in the elderly and have a high 30 day postoperative mortality. The ability to recognize patients at high risk of poor outcomes before operation would be an important clinical advance. This study has determined key prognostic factors predicting 30 day mortality in a hip fracture population, and incorporated them into a scoring system to be used on admission. A cohort study was conducted at the Queen's Medical Centre, Nottingham, over a period of 7 yr. Complete data were collected from 4967 patients and analysed. Forward univariate logistic regression was used to select the independent predictor variables of 30 day mortality, and then multivariate logistic regression was applied to the data to construct and validate the scoring system. The variables found to be independent predictors of mortality at 30 days were: age (66–85 yr, ≥86 yr), sex (male), number of co-morbidities (≥2), mini-mental test score (≤6 out of 10), admission haemoglobin concentration (≤10 g dl−1), living in an institution, and presence of malignant disease. These variables were subsequently incorporated into a risk score, the Nottingham Hip Fracture Score. The number of deaths observed at 30 days, and the number of deaths predicted by the scoring system, indicated good concordance (χ2 test, P=0.79). The area (se) under the receiver operating characteristic curve was 0.719 (0.018), which demonstrated a reasonable predictive value for the score. We have developed and validated a scoring system that reliably predicts the probability of mortality at 30 days for patients after hip fracture.

1 June 2007 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
IMI. K. Moppett
I. K. Moppett
This review examines the evidence base for the early management of head‐injured patients. Traumatic brain injury (TBI) is common, carries a high morbidity and mortality, and has no specific treatment. The pathology of head injury is increasingly well understood. Mechanical forces result in shearing and compression of neuronal and vascular tissue at the time of impact. A series of pathological events may then ensue leading to further brain injury. This secondary injury may be amenable to intervention and is worsened by secondary physiological insults. Various risk factors for poor outcome after TBI have been identified. Most of these are fixed at the time of injury such as age, gender, mechanism of injury, and presenting signs (Glasgow Coma Scale and pupillary signs), but some such as hypotension and hypoxia are potential areas for medical intervention. There is very little evidence positively in favour of any treatments or packages of early care; however, prompt, specialist neurocritical care is associated with improved outcome. Various drugs that target specific pathways in the pathophysiology of brain injury have been the subject of animal and human research, but, to date, none has been proved to be successful in improving outcome.

1 April 2011 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
MWM D Wiles
M D Wiles
CMC.G. Moran
C.G. Moran
OSO. Sahota
O. Sahota
IMI.K. Moppett
I.K. Moppett
Surgical repair of hip fractures is associated with high postoperative mortality. The identification of high-risk patients might be of value in aiding clinical management decisions and resource allocation. The Nottingham Hip Fracture Score (NHFS) is a scoring system validated for the prediction of 30 day mortality after hip fracture surgery. It is made up of seven independent predictors of mortality that have been incorporated into a risk score: age (66-85 and ≥86 yr); sex (male); number of co-morbidities (≥2), admission mini-mental test score (≤6 out of 10), admission haemoglobin concentration (≤10 g dl(-1)), living in an institution; and the presence of malignancy. We investigated whether the NHFS was a predictor of 1 yr mortality in patients undergoing surgical repair of fractured neck of femur. NHFS was retrospectively calculated for 6202 patients who had undergone hip fracture surgery between 1999 and 2009. One year and 30 day postoperative mortality data were collected both from hospital statistics and the Office of National Statistics. Overall mortality was 8.3% at 30 days and 29.3% at 1 yr. An NHFS of ≤4 was considered low risk and a score of ≥5 high risk. Survival was greater in the low-risk group at 30 days [96.5% vs 86.3% (P<0.001)] and at 1 yr [84.1% vs 54.5% (P<0.001)]. NHFS can be used to stratify the risk of 1 yr mortality after hip fracture surgery.

15 January 2014 in Anaesthesia
Verified
Journal Article
Closed access
PDF file
SWS. M. White
S. M. White
IMI. K. Moppett
I. K. Moppett
RGR. Griffiths
R. Griffiths

1 October 2011 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
SHStefan De Hert
Stefan De Hert
GIGeorgina Imberger
Georgina Imberger
JCJohn Carlisle
John Carlisle
PDPierre Diemunsch
Pierre Diemunsch
GFGerhard Fritsch
Gerhard Fritsch
ASAndrew The Task Force On Preoperative Evaluation Of The Adult Noncardiac Surgery Patient Of The European Society Of Anaesthesiology Smith
Andrew The Task Force On Preoperative Evaluation Of The Adult Noncardiac Surgery Patient Of The European Society Of Anaesthesiology Smith
The purpose of these guidelines on the preoperative evaluation of the adult non-cardiac surgery patient is to present recommendations based on available relevant clinical evidence. The ultimate aims of preoperative evaluation are two-fold. First, we aim to identify those patients for whom the perioperative period may constitute an increased risk of morbidity and mortality, aside from the risks associated with the underlying disease. Second, this should help us to design perioperative strategies that aim to reduce additional perioperative risks. Very few well performed randomised studies on the topic are available and many recommendations rely heavily on expert opinion and are adapted specifically to the healthcare systems in individual countries. This report aims to provide an overview of current knowledge on the subject with an assessment of the quality of the evidence in order to allow anaesthetists all over Europe to integrate – wherever possible – this knowledge into daily patient care. The Guidelines Committee of the European Society of Anaesthesiology (ESA) formed a task force with members of subcommittees of scientific subcommittees and individual members of the ESA. Electronic databases were searched from the year 2000 until July 2010 without language restrictions. These searches produced 15 425 abstracts. Relevant systematic reviews with meta-analyses, randomised controlled trials, cohort studies, case–control studies and cross-sectional surveys were selected. The Scottish Intercollegiate Guidelines Network grading system was used to assess the level of evidence and to grade recommendations. The final draft guideline was posted on the ESA website for 4 weeks and the link was sent to all ESA members, individual or national (thus including most European national anaesthesia societies). Comments were collated and the guidelines amended as appropriate. When the final draft was complete, the Guidelines Committee and ESA Board ratified the guidelines.

25 November 2005 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
MSM. Shields
M. Shields
MGM. Giovannelli
M. Giovannelli
RMR. K. Mirakhur
R. K. Mirakhur
IMI. Moppett
I. Moppett
JAJ. Adams
J. Adams
YHY. Hermens
Y. Hermens
Background. Org 25969 is a cyclodextrin compound designed to reverse a rocuronium-induced neuromuscular block. The aim of this study was to explore the efficacy, dose–response relation and safety of Org 25969 for reversal of a prolonged rocuronium-induced neuromuscular block. Methods. Thirty anaesthetized adult patients received rocuronium 0.6 mg kg−1 as an initial dose followed by increments to maintain a deep block at a level of <10 PTCs (post-tetanic counts) recorded every 6 min. Neuromuscular monitoring was carried out using accelerometry, in a train-of-four (TOF) mode using TOF-Watch®SX. At recovery of T2, following at least 2 h of neuromuscular block, patients received their randomly assigned dose of 0.5, 1.0, 2.0, 4.0 or 6.0 mg kg−1 of Org 25969. Anaesthesia and neuromuscular monitoring were continued for a minimum period of 30 min after Org 25969 administration. The main end-point of the study was the time to achieve a sustained recovery of TOF ratio to 0.9. Patients were followed up for 7 days after anaesthesia. Results. The results showed a dose-related decrease in the average time taken to attain a TOF ratio of 0.9 from 6:49 (min:s) with the 0.5 mg kg−1 dose to 1:22 with the 4.0 mg kg−1 dose. Weighted non-linear regression analysis showed the fastest achievable time to TOF ratio of 0.9 to be 1:35. Org 25969 produced no major adverse effects. Conclusion. Org 25969 effectively reversed a deep and prolonged neuromuscular block induced by rocuronium. The effective reversal dose appears to be 2–4 mg kg−1.